Phase I and II trials of novel anti-cancer agents: Endpoints, efficacy and existentialism

This publication has 4 references indexed in Scilit:

• PET scanning in clinical oncology
  Annals of Oncology, 1998
• Suramin-Induced Decrease in Prostate-Specific Antigen Expression With No Effect on Tumor Growth in the LNCaP Model of Human Prostate Cancer
  JNCI Journal of the National Cancer Institute, 1996
• A80 Design of Phase II clinical trials incorporating response and early progression
  Controlled Clinical Trials, 1996
• Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial.
  Journal of Clinical Oncology, 1988